Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton
March 5, 2018
Biographies: Robert J. Hamilton, MD, MPH, FRCSC - Dr. Hamilton completed his medical school and urology residency at the University of Toronto. During residency he completed a Masters of Public Health (MPH) from the University of North Carolina at Chapel Hill and a research fellowship at Duke University. Before joining the faculty, he completed a fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Centre in New York City.
His clinical practice focuses on management of genitourinary malignancies, with particular focus on prostate and testis cancers. This includes minimally invasive surgical techniques. His research interests focus on the epidemiology of urological malignancies and biomarkers in risk and progression of these diseases.
E. David Crawford, MD
Read More Related Content:
Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases - results of a feasibility and case-control study
Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review